UNSPSC 51161715: Dimefline

This classification denotes a cns stimulant with the molecular formula C20H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9WII5M0DU3, chemically known as 4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl- (9ci) but generally known as dimefline, which bears US NIH Compound Identifier 3078. European Medicines Agency schedules Dimefline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07156MIG.

UNSPSC 51161715 Dimefline is a Commodity code under which state and local governments procure pharmaceutical products and pharmacy-related services, including naloxone, drug deactivation systems, and comprehensive on-site pharmacy dispensing and management. The recent opportunities under this code reflect a mix of emergency-response procurement and occupational health service delivery, with county health departments and local government workforce health programs as primary issuing bodies. Seminole County, Florida issued a competitive bid (IFB) to procure naloxone and drug deactivation systems to support community health initiatives, while Hall County, Georgia issued a Request for Qualifications with Cost Proposal (RFQ/P) for an on-site pharmacy services provider to serve county employees, retirees, and eligible dependents through the county's group health plan. Both solicitations require vendors to demonstrate E-Verify compliance, maintain specified insurance coverage, and meet HIPAA and federal regulatory standards when applicable.

Activity under the code appears concentrated in the Southeast, with recent postings from Florida and Georgia. Seminole County's naloxone procurement (IFB 60459723LAS, response deadline July 26, 2023) called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and potential FEMA funding. Hall County's pharmacy services RFQ/P (#47-010, response deadline June 4, 2026) sought a single vendor to provide comprehensive pharmacy services to approximately 3,005 eligible individuals enrolled in the county's group health plans, with contract start January 1, 2027, and an initial one-year term plus four optional one-year renewals. The Hall County solicitation weighted technical qualifications at 80% and cost at 20%, requiring vendors to stock and dispense a specified 25-medication formulary and demonstrate capability across multiple therapeutic categories. Neither solicitation disclosed an explicit budget or award ceiling, and neither offered set-aside designations for disadvantaged enterprises.